Author:
Ryo Ryukichi,Yoshida Akinori,Sugano Wataru,Yasunaga Mutsumi,Nakayama Katsuji,Saigo Katsuyasu,Adachi Masashi,Yamaguchi Nobuo,Okuma Minoru
Cited by
83 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. From Patients to Platelets and Back Again: Pharmacological Approaches to Glycoprotein VI, a Thrilling Antithrombotic Target with Minor Bleeding Risks;Thrombosis and Haemostasis;2019-09-29
2. Molecular modelling studies in explaining the higher GPVI antagonistic activity of the racemic 2-(4-methoxyphenylsulfonyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide than its enantiomers;SAR and QSAR in Environmental Research;2017-10-03
3. Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention;Advances in Interventional Cardiology;2017
4. Platelet Adhesive Protein Defect Disorders;Platelets in Thrombotic and Non-Thrombotic Disorders;2017
5. Novel Glycoprotein VI Antagonists as Antithrombotics: Synthesis, Biological Evaluation, and Molecular Modeling Studies on 2,3-Disubstituted Tetrahydropyrido(3,4-b)indoles;Journal of Medicinal Chemistry;2016-12-20